189 related articles for article (PubMed ID: 18497715)
1. The search for medications to treat stimulant dependence.
Kampman KM
Addict Sci Clin Pract; 2008 Jun; 4(2):28-35. PubMed ID: 18497715
[TBL] [Abstract][Full Text] [Related]
2. Response: anticipating new medications.
Bogenschutz MP; DeMarzo LJ; Roll J
Addict Sci Clin Pract; 2008 Jun; 4(2):36-8. PubMed ID: 18497716
[No Abstract] [Full Text] [Related]
3. Novel medications to treat addictive disorders.
Montoya ID; Vocci F
Curr Psychiatry Rep; 2008 Oct; 10(5):392-8. PubMed ID: 18803912
[TBL] [Abstract][Full Text] [Related]
4. Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies.
MartÃnez-Raga J; Knecht C; Cepeda S
Curr Drug Abuse Rev; 2008 Jun; 1(2):213-21. PubMed ID: 19630720
[TBL] [Abstract][Full Text] [Related]
5. Psychostimulant treatment of cocaine dependence.
Mariani JJ; Levin FR
Psychiatr Clin North Am; 2012 Jun; 35(2):425-39. PubMed ID: 22640764
[TBL] [Abstract][Full Text] [Related]
6. Management of methamphetamine abuse and dependence.
Ling W; Rawson R; Shoptaw S; Ling W
Curr Psychiatry Rep; 2006 Oct; 8(5):345-54. PubMed ID: 16968614
[TBL] [Abstract][Full Text] [Related]
7. Use of stimulants to treat cocaine and methamphetamine abuse.
Moeller FG; Schmitz JM; Herin D; Kjome KL
Curr Psychiatry Rep; 2008 Oct; 10(5):385-91. PubMed ID: 18803911
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
9. Normalizing effects of modafinil on cocaine-induced sleep abnormalities.
Dackis C; O'Brien CP
Am J Psychiatry; 2010 Mar; 167(3):248-9. PubMed ID: 20194486
[No Abstract] [Full Text] [Related]
10. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.
Leventhal AM; Kahler CW; Ray LA; Stone K; Young D; Chelminski I; Zimmerman M
Am J Addict; 2008; 17(3):218-23. PubMed ID: 18463999
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
[TBL] [Abstract][Full Text] [Related]
14. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
Hester R; Lee N; Pennay A; Nielsen S; Ferris J
Exp Clin Psychopharmacol; 2010 Dec; 18(6):489-97. PubMed ID: 21186923
[TBL] [Abstract][Full Text] [Related]
15. The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
Rawls SM; Cavallo F; Capasso A; Ding Z; Raffa RB
Eur J Pharmacol; 2008 Apr; 584(2-3):278-84. PubMed ID: 18342307
[TBL] [Abstract][Full Text] [Related]
16. Impulsivity is associated with treatment non-completion in cocaine- and methamphetamine-dependent patients but differs in nature as a function of stimulant-dependence diagnosis.
Winhusen T; Lewis D; Adinoff B; Brigham G; Kropp F; Donovan DM; Seamans CL; Hodgkins CC; Dicenzo JC; Botero CL; Jones DR; Somoza E
J Subst Abuse Treat; 2013; 44(5):541-7. PubMed ID: 23305820
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results.
Stitzer ML; Petry N; Peirce J; Kirby K; Killeen T; Roll J; Hamilton J; Stabile PQ; Sterling R; Brown C; Kolodner K; Li R
J Consult Clin Psychol; 2007 Oct; 75(5):805-11. PubMed ID: 17907862
[TBL] [Abstract][Full Text] [Related]
18. Emerging pharmacological strategies in the fight against cocaine addiction.
Sofuoglu M; Kosten TR
Expert Opin Emerg Drugs; 2006 Mar; 11(1):91-8. PubMed ID: 16503828
[TBL] [Abstract][Full Text] [Related]
19. Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the Netherlands.
Nuijten M; Blanken P; van den Brink W; Hendriks V
BMC Psychiatry; 2011 Aug; 11():135. PubMed ID: 21854580
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacotherapy of substance dependence and withdrawal syndromes].
Walter M; Wiesbeck GA
Ther Umsch; 2009 Jun; 66(6):449-57. PubMed ID: 19496041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
